VIB is proud today to share V-Bio Ventures' announcement on the first close of their second fund at 78 million euros. V-Bio Fund 2 builds on the success of V-Bio's first fund, with 15 investments in outstanding companies that innovate in healthcare and agriculture. V-Bio Ventures’ portfolio companies are spread across Europe, with the majority of them located in the Flanders region.
“V-Bio Ventures was set up in 2015, co-founded by VIB. The timing was just right as the local ecosystem was short of an early-stage investment fund. With its first fund, V-Bio Ventures backed no fewer than 7 VIB start-up companies,“ says Griet Vanpoucke, VIB’s Head of New Ventures.
Jérôme Van Biervliet, managing director at VIB, adds: “VIB congratulates the V-Bio team on the exciting first close of the second fund and looks forward to extending it. As co-founder of V-Bio Ventures and through their many investments in VIB’s start-ups, we have formed a privileged relationship. We have witnessed V-Bio Ventures become a powerful force in our biotech ecosystem, creating significant value beyond the deal. Their scientific expertise, market feedback and extensive network is of crucial value to VIB, in addition to their investment capacity.”